Agios Pharmaceuticals (AGIO) Q1 2026 Earnings

Feb 12Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-1.95
-1.82
-1.68
-1.55

Details

Expected EPS
-1.953708
Actual EPS
-1.86
Surprise EPS
0.09
Surprise Percent
+4.8%

Description

⁨Agios Pharmaceuticals⁩ (⁦AGIO⁩) has reported earnings of ⁦-1.86⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts